Nomura Holdings Inc Chemo Centryx, Inc. Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$13.18 - $19.83 $619,460 - $932,009	-47,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $450,730 - $2.39 Million	47,000 New	47,000 $631,000
Q1 2021 May 17, 2021	SELL	$49.53 - $68.4 $212,979 - $294,120	-4,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$47.25 - $65.16 $203,175 - $280,188	4,300 New	4,300 $266,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.